99 posters, 2 videos, 5 audios, 13 topics, 7 sessions, 418 authors, 180 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
The 21st Meeting of the Diabetic Foot Study Group 2026
24-26 September, 2026 | Florence, Italy
EP62
Topical Wound Oxygen Therapy could be an adjunct to management of Ischaemic Diabetic Foot while awaiting definitive vascular intervention: A single centre case series
Poster Presenter
Authors
Oluwatoyin Akinjola, Christina Martin, Mercy Laryea, Rebecca Neale, Maureen Bates, Ben So, Patricia Lee, Bonnie Chow, Enid Joseph, Stanley Ebiogwu, Michael Edmonds, Erika Vainieri, Chris Manu
Affiliations
Mike Edmonds Foot Unit, King'S College Hospital NHS Foundation Trust, London, United Kingdom, King'S College Hospital NHS Foundation Trust, London, United Kingdom
Part of Topic
Wound healing and outcome
Background & Aim: Randomised control trials, have demonstrated the benefit of at home Topical Wound Oxygen (TWO2) therapy as an adjunct to Standard of Care (SOC) for diabetic foot ulcers (DFU). The aim was to demonstrate the possibility of using TWO2 therapy as an adjunct for the management of patients within the hospital setting or foot clinic.
Method: This was a retrospective review of 3 cases with and ischaemic foot (CLTI), who underwent TWO2 therapy in addition to their SOC while awaiting or undergoing their vascular intervention.
Conclusion: There is the scope to use TWO2 treatment as an adjunct to SOC in complex ischaemic diabetic foot. Both pre/post revascularisation or pre amputation with potential to improve skin quality and swelling.